Virtual Molecular Masterclass Explores Therapeutic Potential and Medicalization of Ibogaine

[ad_1]

(YourDigitalWall Editorial):- Toronto, Jan 13, 2021 (Issuewire.com) – Microdose Psychedelic Insights, along with Universal Ibogaine, and The Conscious Fund, present The Ibogaine Conference: A Molecular Masterclass, a two-day virtual conference. The online conference will take place on 19th – 20th February 2021.  

The conference will bring together over 50 of the leading researchers in the therapeutic use of Ibogaine, a powerful psychedelic plant medicine showing ...

Continue Reading →

Ibogaine Treatment and the Opioid Crisis: Past, Present, and Future



Ibogaine Treatment and the Opioid Crisis: Past, Present, and Future
Thomas Kingsley Brown, Ph.D.

The Sleeping Octopus Assembly on Psychedelics (SOAP) is an intimate conference that explored the role of psychedelics in science, medicine, policy, and culture, which took place at a historic mansion in Pittsburgh, Pennsylvania, from July 13-15, 2018.

This conference featured presentations from key figures in the psychedelic research and policy community, a psychedelic-themed comedy show, ...

Continue Reading →

Amanda Feilding: From Taboo to Treatment: The Coming of Age of Psychedelic Medicine



Learn more and donate: http://www.maps.org/

Amanda Feilding: From Taboo to Treatment – The Evolution of Psychedelic Medicine

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

James Fadiman & Sophia Korb: Microdosing – The Phenomenon, Research Results & Startling Surprises



Learn more and donate: http://www.maps.org/

James Fadiman, PhD, and Sophia Korb, PhD
Microdosing: The Phenomenon, Research Results, and Startling Surprises

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

Franz Vollenweider: 5HT2A Receptor Agonists & Mood Disorders – Mood, Empathy & Social Pain



Learn more and donate: http://www.maps.org/

Franz Vollenweider, MD
Psychedelic 5HT2A Receptor Agonists
Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →
Page 1 of 2 12
UA-77446339-1